Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration

Neovascular age-related macular degeneration (nAMD) treatment has been revolutionized by the introduction of vascular endothelial growth factor antagonists (anti-VEGF), but the need for frequent intravitreal injections poses a heavy burden to patients and physicians. Evolving anti-VEGF therapies inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Rehan M, Shaukat, Bilal A, Ciulla, Lauren M, Berrocal, Audina M, Sridhar, Jayanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232378/
https://www.ncbi.nlm.nih.gov/pubmed/34188445
http://dx.doi.org/10.2147/DDDT.S295223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232378/
https://www.ncbi.nlm.nih.gov/pubmed/34188445
http://dx.doi.org/10.2147/DDDT.S295223

Ejemplares similares